Jim Dorst

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jim Dorst

Jim Dorst is recorded as Board Member at Sigyn Therapeutics, Inc. (SIGY). Sigyn Therapeutics, Inc. reported in an 8-K filed October 5, 2022 that Jim Dorst was appointed Director, effective October 10, 2022.

“The Board of Directors of Sigyn Therapeutics, Inc. ("the Company") appointed Jim Dorst, Richa Nand, and Christopher Wetzel to the Company's Board of Directors effective as of October 10, 2022.”

Sigyn Therapeutics, Inc. Form 8-K, filed October 5, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Jim Dorst's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Sigyn Therapeutics, Inc. (SIGY)
Board Member

SEC 8-K

Current
2022-10-10–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Sigyn Therapeutics, Inc.

SIGY

Current role

Board Member

2022-10-10–present

Leadership on record at Sigyn Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

James Joyce CEO, Chairman, Board Member
Jerry DeCiccio CFO
Craig Roberts CTO, Board Member
Christopher Wetzel Board Member
Michael Ryan Board Member
Richa Nand Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Director Sigyn Therapeutics, Inc. (SIGY)
2022-10-10